Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative docetaxel with or without trastuzumab in locally advanced breast cancer stratified by HER2 status
2005-000967-24Phase 2Completed
- Sponsor
- Technical University of Munich
- Start
- Aug 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel and trastuzumab in breast cancer (2 arms), sponsored by Technical University of Munich. Primary endpoints: Pathologic complete remission rate and Correlation with predictive factors. Started Aug 2005; status: completed.
02
Drugs
docetaxeltrastuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-000967-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000967-24.